1. Home
  2. CAE vs ROIV Comparison

CAE vs ROIV Comparison

Compare CAE & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$30.93

Market Cap

8.5B

Sector

N/A

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.87

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
ROIV
Founded
1947
2014
Country
Canada
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
14.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CAE
ROIV
Price
$30.93
$21.87
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$33.75
$24.31
AVG Volume (30 Days)
572.2K
8.3M
Earning Date
02-12-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
N/A
Revenue
$3,470,482,234.00
$20,329,000.00
Revenue This Year
$6.40
N/A
Revenue Next Year
$5.37
$741.42
P/E Ratio
$31.79
N/A
Revenue Growth
9.12
N/A
52 Week Low
$20.36
$8.73
52 Week High
$31.68
$23.47

Technical Indicators

Market Signals
Indicator
CAE
ROIV
Relative Strength Index (RSI) 65.81 56.28
Support Level $30.38 $21.36
Resistance Level $31.68 $22.72
Average True Range (ATR) 0.67 0.72
MACD 0.06 -0.13
Stochastic Oscillator 76.95 32.69

Price Performance

Historical Comparison
CAE
ROIV

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: